Drug profile · INN
omega-3-acid ethyl esters type a
OMTRYG
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
omega-3-acid ethyl esters type a (OMTRYG) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN omega-3-acid ethyl esters type a
Brand OMTRYG
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is omega-3-acid ethyl esters type a?
omega-3-acid ethyl esters type a (OMTRYG) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for omega-3-acid ethyl esters type a?
OMTRYG is a marketed brand name for omega-3-acid ethyl esters type a. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of omega-3-acid ethyl esters type a?
omega-3-acid ethyl esters type a has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.